MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis
Ni Wang,1,* Yang Cao,2,* Xianxiu Ge,1,* Junjie Nie,1 Yang Yu,1 Quanpeng Li,1 Fei Wang,1 Lin Miao11Medical Center for Digestive Diseases, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China; 2Department of General Surgery, The Second...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/microrna-195-as-a-prognostic-factor-for-cancer-survival-outcome-in-chi-peer-reviewed-article-CMAR |
| _version_ | 1828401223121764352 |
|---|---|
| author | Wang N Cao Y Ge X Nie J Yu Y Li Q Wang F Miao L |
| author_facet | Wang N Cao Y Ge X Nie J Yu Y Li Q Wang F Miao L |
| author_sort | Wang N |
| collection | DOAJ |
| description | Ni Wang,1,* Yang Cao,2,* Xianxiu Ge,1,* Junjie Nie,1 Yang Yu,1 Quanpeng Li,1 Fei Wang,1 Lin Miao11Medical Center for Digestive Diseases, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China; 2Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of ChinaCorrespondence: Lin MiaoDepartment of Gastroenterology, The Second Affiliated Hospital of Nanjing Medical University, 121 Jiangjiayuan, Nanjing, Jiangsu Province 210011, People’s Republic of ChinaEmail linmiao@njmu.edu.cn*These authors contributed equally to this workPurpose: MicroRNA-195 is dysregulated in different kinds of cancers and plays a pivotal role in tumorigenesis. It may function as a prognostic biomarker for cancers. However, the results from articles were not consistent. This study was designed to validate the prognostic value of microRNA-195 in human tumors.Methods: We conducted a detailed search on PubMed until December 31, 2018. The quality of these publications was assessed on the basis of a list of key reviews presented by PRISMA statement. The pooled hazard ratios (HR) and pooled odds ratios (OR) of each 95% confidence interval (95% CI) were calculated to assess the effect.Results: This meta-analysis included 12 studies involving 940 cancer patients to assess the prognostic value of miR-195 in different solid tumors. The results showed that patients with high expression of miR-195 had favorable tumor-node-metastasis (late vs early: pooled OR =0.16, 95% CI: 0.11–0.22, P<0.001), lymph node metastasis (pooled OR =0.25, 95% CI: 0.18–0.35, P<0.001) and distant metastasis (pooled OR =0.26, 95% CI: 0.13–0.52, P<0.001). At the same time, high levels of miR-195 expression were closely correlated with better overall survival (pooled HR =0.46, 95% CI: 0.36–0.58, P<0.001).Conclusion: Elevated microRNA-195 may serve as a potential biomarker to predict a favorable prognosis for various cancer types in China.Keywords: biomarker, prognosis, microRNA-195, expression, meta-analysis |
| first_indexed | 2024-12-10T09:43:26Z |
| format | Article |
| id | doaj.art-c16a8940d3644832bd5149d898f7d4ec |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-12-10T09:43:26Z |
| publishDate | 2019-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-c16a8940d3644832bd5149d898f7d4ec2022-12-22T01:53:55ZengDove Medical PressCancer Management and Research1179-13222019-08-01Volume 117967797948056MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysisWang NCao YGe XNie JYu YLi QWang FMiao LNi Wang,1,* Yang Cao,2,* Xianxiu Ge,1,* Junjie Nie,1 Yang Yu,1 Quanpeng Li,1 Fei Wang,1 Lin Miao11Medical Center for Digestive Diseases, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China; 2Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of ChinaCorrespondence: Lin MiaoDepartment of Gastroenterology, The Second Affiliated Hospital of Nanjing Medical University, 121 Jiangjiayuan, Nanjing, Jiangsu Province 210011, People’s Republic of ChinaEmail linmiao@njmu.edu.cn*These authors contributed equally to this workPurpose: MicroRNA-195 is dysregulated in different kinds of cancers and plays a pivotal role in tumorigenesis. It may function as a prognostic biomarker for cancers. However, the results from articles were not consistent. This study was designed to validate the prognostic value of microRNA-195 in human tumors.Methods: We conducted a detailed search on PubMed until December 31, 2018. The quality of these publications was assessed on the basis of a list of key reviews presented by PRISMA statement. The pooled hazard ratios (HR) and pooled odds ratios (OR) of each 95% confidence interval (95% CI) were calculated to assess the effect.Results: This meta-analysis included 12 studies involving 940 cancer patients to assess the prognostic value of miR-195 in different solid tumors. The results showed that patients with high expression of miR-195 had favorable tumor-node-metastasis (late vs early: pooled OR =0.16, 95% CI: 0.11–0.22, P<0.001), lymph node metastasis (pooled OR =0.25, 95% CI: 0.18–0.35, P<0.001) and distant metastasis (pooled OR =0.26, 95% CI: 0.13–0.52, P<0.001). At the same time, high levels of miR-195 expression were closely correlated with better overall survival (pooled HR =0.46, 95% CI: 0.36–0.58, P<0.001).Conclusion: Elevated microRNA-195 may serve as a potential biomarker to predict a favorable prognosis for various cancer types in China.Keywords: biomarker, prognosis, microRNA-195, expression, meta-analysishttps://www.dovepress.com/microrna-195-as-a-prognostic-factor-for-cancer-survival-outcome-in-chi-peer-reviewed-article-CMARbiomarkerprognosismicroRNA-195expressionmeta-analysis |
| spellingShingle | Wang N Cao Y Ge X Nie J Yu Y Li Q Wang F Miao L MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis Cancer Management and Research biomarker prognosis microRNA-195 expression meta-analysis |
| title | MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis |
| title_full | MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis |
| title_fullStr | MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis |
| title_full_unstemmed | MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis |
| title_short | MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis |
| title_sort | microrna 195 as a prognostic factor for cancer survival outcome in china a meta analysis |
| topic | biomarker prognosis microRNA-195 expression meta-analysis |
| url | https://www.dovepress.com/microrna-195-as-a-prognostic-factor-for-cancer-survival-outcome-in-chi-peer-reviewed-article-CMAR |
| work_keys_str_mv | AT wangn microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT caoy microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT gex microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT niej microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT yuy microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT liq microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT wangf microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis AT miaol microrna195asaprognosticfactorforcancersurvivaloutcomeinchinaametaanalysis |